drugset
drugset / Trial / NCT06325761

A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects

NCT06325761 ↗

Phase 1 Unknown 28 enrolled Shouyao Holdings (Beijing) Co. LTD
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a single-center, randomized, open-label, single-dose, two-period, two-treatment crossover trial aimed at evaluating the pharmacokinetic (PK) profiles and safety of SY-5007 tablets administered orally to healthy subjects in both fasting and fed states in China.

Timeline

Start
2024-04-01
Primary completion
2024-05-01
Completion
2024-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject SY-5007 Unknown 160 mg Oral

Indications

No indication recorded.